Previous studies showed that SPOCK presented high plasma levels in multiple cancers and could promote tumor growth, metastasis, and invasion through PI3K/Akt, Wnt/β-catenin, and other pathways, and increase cancer cell resistance to chemotherapeutic drugs [22, 23]. This evidence concerns the gene SPOCK1 and neoplasm.